| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |